Article
Identification of Epstein-Barr Virus–Induced Gene 3 as a Novel Serum and Tissue Biomarker and a Therapeutic Target for Lung Cancer
17 Aug 2011
Abstract excerpt
PURPOSE: This study aims to identify novel biomarkers and therapeutic targets for lung cancer. EXPERIMENTAL DESIGN: We carried out gene expression profile analysis of 120 lung cancers to screen for genes encoding transmembrane/secretory molecules that are commonly transactivated in lung cancers. Epstein-Barr virus-induced gene 3 (EBI3), which encodes a secretory glycoprotein, was selected as a good candidate....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
